Fennec Pharmaceuticals Inc. · NASDAQ:FENC
Fennec Pharmaceuticals Inc. shareholders
As of Sep 30, 2026, 115 institutions reported holding Fennec Pharmaceuticals Inc., 50.9% of its shares. Largest: Rosalind Advisors, Inc., AIGH Capital Management LLC and BlackRock. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Fennec Pharmaceuticals Inc. | Change | Filed |
|---|---|---|---|---|
| Rosalind Advisors, Inc. | 3.19M | 9.0% | no change | Nov 16, 2026 |
| AIGH Capital Management LLC | 2.5M | 7.1% | +13,383 | Nov 2, 2026 |
| BlackRock | 2.03M | 5.8% | +306K | Nov 13, 2026 |
| Solas Capital Management, LLC | 1.43M | 4.1% | −456K | Nov 16, 2026 |
| AWM Investment Company, Inc. | 1.16M | 3.3% | no change | Nov 13, 2026 |
| Vanguard | 1.09M | 3.1% | +2,453 | Nov 13, 2026 |
| Prospect Capital Advisors, LLC | 887K | 2.5% | +389K | Nov 16, 2026 |
| State Street | 426K | 1.2% | −315 | Nov 12, 2026 |
| Geode Capital | 409K | 1.2% | +6,495 | Nov 6, 2026 |
| Essex Investment Management Co LLC | 319K | 0.90% | new | Oct 19, 2026 |